10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2014

or

o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________

Commission File Number 333-187308

NANOFLEX POWER CORPORATION

(Exact name of registrant as specified in its charter)

Florida	46-1904002
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
17207 N Perimeter Dr., Suite 210
Scottsdale, AZ	85255
(Address of principal executive offices)	(Zip Code)

480-585-4200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x   No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x   No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
(Do not check if smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)  Yes  o   No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 44,282,278 shares of common stock are issued and outstanding as of November 7, 2014.

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS	3
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	9
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	12
ITEM 4.	CONTROLS AND PROCEDURES	12
PART II.	OTHER INFORMATION
ITEM 1A.	RISK FACTORS	14
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	14
ITEM 6.	EXHIBITS	14
SIGNATURES		15

2

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CONTENTS

FINANCIAL STATEMENTS	Page
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)	4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)	5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)	6
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)	7

3

NANOFLEX POWER CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2014			December 31, 2013
	(unaudited)
ASSETS
CURRENT ASSETS:
Cash	$	51,011		$	197,004
Prepaid expenses and other current assets		8,624			13,645
Total current assets		59,635			210,649
Property and equipment, net		15,083			7,433
TOTAL ASSETS	$	74,718		$	218,082
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable	$	1,671,986		$	689,119
Accrued expenses		1,319,877			676,752
Short-term debt		600,000			100,000
Short-term debt- related party		90,000			-
Advances - related party		210,000			-
Total current liabilities		3,891,863			1,465,871
TOTAL LIABILITIES		3,891,863			1,465,871
STOCKHOLDERS' DEFICIT:
Common stock, 250,000,000 authorized, $0.0001 par value, 44,282,278 and 42,799,278 issued and outstanding, respectively		4,428			4,280
Additional paid in capital		172,864,561			171,010,959
Accumulated deficit		(176,686,134	)		(172,263,028	)
Total stockholders' deficit		(3,817,145	)		(1,247,789	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	74,718		$	218,082

See accompanying notes to unaudited condensed consolidated financial statements.

4

NANOFLEX POWER CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2014			2013			2014			2013
OPERATING EXPENSES:
Research and development	$	291,571		$	412,440		$	996,722		$	956,211
Patent application and prosecution fees		625,596			690,996			1,367,998			1,263,417
Salaries and related expenses		399,164			835,985			1,241,256			1,373,281
Stock-based compensation		-			6,657,689			-			26,064,190
Selling, general and administrative expenses		288,904			832,414			774,499			1,143,121
Total operating expenses		1,605,235			9,429,524			4,380,475			30,800,220
LOSS FROM OPERATIONS		1,605,235			9,429,524			4,380,475			30,800,220
OTHER INCOME (EXPENSES):
Interest expense		(42,631	)		(17,932	)		(42,631	)		(4,463,453	)
Loss on extinguishment of debt		-			-			-			(1,811,800	)
Total other expense		(42,631	)		(17,932	)		(42,631	)		(6,275,253	)
LOSS BEFORE INCOME TAX BENEFIT		1,647,866			9,447,456			4,423,106			37,075,473
INCOME TAX BENEFIT		-			-			-			-
NET LOSS	$	(1,647,866	)	$	(9,447,456	)	$	(4,423,106	)	$	(37,075,473	)
NET LOSS per share (basic and diluted)	$	(0.04	)	$	(0.42	)	$	(0.10	)	$	(0.61	)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC and DILUTED		43,923,961			22,589,971			43,420,085			61,079,624

See accompanying notes to unaudited condensed consolidated financial statements.

5

NANOFLEX POWER CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

	Nine Months Ended September 30,
	2014			2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(4,423,106	)	$	(37,075,473	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		2,414			2,879
Amortization of debt discounts		-			45,421
Stock-based compensation		-			26,064,190
Interest expense from convertible debt converted to preferred shares		-			57,915
Interest expense from additional common shares issued		-			4,015,040
Loss on extinguishment of debt		-			1,811,800
Return of equity investment		-			(222,500	)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		5,021			12,784
Accounts payable and accrued expenses		1,625,992			(1,946,512	)
Net cash used in operating activities		(2,789,679	)		(7,234,456	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of fixed assets		(10,064	)		-
Common shares issued in reverse merger, net		-			5,049
Net cash used in investing activities		(10,064	)		5,049
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of warrants		-			176,819
Proceeds from sale of common shares and warrants		1,853,750			1,050,000
Advances received from related party		443,000			-
Advances repaid to related party		(233,000	)		-
Borrowings on related party debt		150,000			240,000
Borrowings on convertible debt - related party		-			6,800,000
Borrowings on debt		500,000			-
Borrowing on convertible debt		-			2,124,500
Principal repayments on debt		-			(1,725,000	)
Principal repayments on related party debt		(60,000	)		(640,000	)
Net cash provided by financing activities		2,653,750			8,026,319
NET DECREASE IN CASH		(145,993	)		796,912
Cash, beginning of the period		197,004			344,656
Cash, end of the period	$	51,011		$	1,141,568
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest	$	-		$	714,036
Cash paid for income taxes	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES
Warrants and common shares issued for debt		-			230,000
Common share issued for forgiveness of related party debt		-			105,000
Short term debt converted into convertible short term debt		-			-
Common shares issued for conversion of convertible debt upon merger		-			11,433,200

See accompanying notes to unaudited condensed consolidated financial statements.

6

NANOFLEX POWER CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. BACKGROUND, BASIS OF PRESENTATION, AND GOING CONCERN:

Background

Global Photonic Energy Corporation merged with NanoFlex Power Corporation (formerly, Universal Technology Systems Corp., the “Company”) in a share exchange transaction recorded as a reverse merger on September 24, 2013.  The Company is organized to fund, develop and commercialize photonic energy conversion technologies utilizing organic semiconductor-based solar cells.  The Company intends to enter into licensing arrangements and other strategic alliances for the development, manufacture and marketing of products utilizing this technology. The Company is devoting substantially all of its present efforts to establishing a new business.

Basis or Presentation

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the fiscal year ended December 31, 2013 included in our Annual Report on Form 10-K. The results of operations for the three and nine months ended September 30, 2014 are not necessarily indicative of results to be expected for the full fiscal year or any other periods.

The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make a number of estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosures. Actual results may differ from these estimates.

In the quarter ending September 30, 2014, the Company has elected to early adopt Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. The adoption of this ASU allows the Company to remove the inception to date information and all references to development stage.

Going Concern

The Company has not generated revenues to date.  The Company has a working capital deficit of ($3,832,228) and an accumulated deficit of ($176,686,134) as of September 30, 2014.  The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations.  Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. To date, the Company has funded its initial operations primarily by way of the sale of equity securities, convertible note financing, short term financing from private parties, and advances from related parties.

2. NOTES PAYABLE

In July 2014, the Company borrowed $500,000 under two short term note agreements of $250,000 each. Under the terms of each agreement, the principal balance of $250,000 and interest of $16,500 is due to be repaid within 4 months of the date of the note. At September 30, 2014, $33,000 was recorded as accrued interest relating to these notes.

3. NOTES PAYABLE - RELATED PARTY

On February 26, 2014, the Company borrowed $150,000 under a short term note agreement with a related party. Under the terms of this agreement, this note is due to be repaid within 6 months of funding and is non-interest bearing.  If the Company defaults on this agreement, the note shall bear interest at a rate of 18 percent per annum for the entire term of the note. In November 2014, the note agreement was amended to extend the due date to February 26, 2015, 12 months from the date of the note. As of September 30, 2014, $90,000 is due under this agreement.

During the three months ended September 30, 2014, the Company received advances totaling $76,000 and repaid advances totaling $155,000. During the nine months ended September 30, 2014, the Company received advances totaling $443,000 and repaid advances totaling $233,000.

4. EQUITY

During the nine months ended September 30, 2014, the Company sold an aggregate of 1,483,000 units at $1.25 per unit for aggregate proceeds of $1,853,750. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.

7

5. STOCK OPTIONS AND WARRANTS

2000 Stock Option Plan

On April 28, 2000, the Board of Directors adopted the 2000 Stock Option Plan.  Under the Plan, the Company may grant incentive stock options to employees and non-qualified stock options to employees, non-employee directors and/or consultants. The Plan provides for the granting of a maximum of 2,000,000 options to purchase common stock.  The ISO exercise price per share may not be less than the fair market value of a share on the date the option is granted.  The maximum term of the options may not exceed ten years.

A summary of stock option activity during the nine months ended September 30, 2014 is as follows:

						Weighted Average
				Weighted		Remaining
				Average		Contractual		Aggregate
	Number of			Exercise		Term		Intrinsic
	Shares			Price		(in years)		Value
Outstanding as of December 31, 2013		105,000		$	11.03		2.6	$	-
Granted		-
Cancelled		(47,000	)	$	10.31
Exercised		-
Outstanding as of September 30, 2014		58,000		$	11.62		3.2	$	-
Exercisable as of September 30, 2014		58,000		$	11.62		3.2	$	-

The exercise price of these options range from $10.00 to $15.00 per share.

A summary of warrant activity during the nine months ended September 30, 2014 is as follows:

					Weighted Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Term		Intrinsic
	Shares		Price		(in years)		Value
Outstanding as of December 31, 2013		19,556,983	$	3.60		4.7	$	-
Granted		1,483,000	$	2.50
Cancelled		-
Exercised		-
Outstanding as of September 30, 2014		21,039,983	$	3.02		4.5	$	-
Exercisable as of September 30, 2014		21,039,983	$	3.02		4.5	$	-

The exercise price of these warrants ranges from $2.50 to $17.50 per share.

During the three months ended March 31, 2014, the Company modified an aggregate of 860,150 of warrants to reduce their exercise price from a range of $12.00 to $17.50 per share to $2.50 per share.  All other terms and conditions remained the same.  The Company determined that this transaction did not constitute a modification under ASC 718-10 or ASC 505-50 as it met the scope exceptions for a transaction with an investor or lender.  Accordingly, no expense was recognized in connection with these transactions. 

6. SUBSEQUENT EVENTS

In October 2014, a permanent decrease in salaries was negotiated with the Company’s employees in an effort to conserve capital resources.

8

ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2013 and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in our Annual Report on Form 10-K filed on March 31, 2014.

SPECIAL NOTE OF CAUTION REGARDING FORWARD-LOOKING STATEMENTS

CERTAIN STATEMENTS IN THIS REPORT, INCLUDING STATEMENTS IN THE FOLLOWING DISCUSSION, ARE WHAT ARE KNOWN AS "FORWARD-LOOKING STATEMENTS", WHICH ARE BASICALLY STATEMENTS ABOUT THE FUTURE. FOR THAT REASON, THESE STATEMENTS INVOLVE RISK AND UNCERTAINTY SINCE NO ONE CAN ACCURATELY PREDICT THE FUTURE. WORDS SUCH AS "PLANS," "INTENDS," "WILL," "HOPES," "SEEKS," "ANTICIPATES," "EXPECTS" AND THE LIKE OFTEN IDENTIFY SUCH FORWARD-LOOKING STATEMENTS, BUT ARE NOT THE ONLY INDICATION THAT A STATEMENT IS A FORWARD-LOOKING STATEMENT. SUCH FORWARD-LOOKING STATEMENTS INCLUDE STATEMENTS CONCERNING OUR PLANS AND OBJECTIVES WITH RESPECT TO THE PRESENT AND FUTURE OPERATIONS OF THE COMPANY, AND STATEMENTS WHICH EXPRESS OR IMPLY THAT SUCH PRESENT AND FUTURE OPERATIONS WILL OR MAY PRODUCE REVENUES, INCOME OR PROFITS. NUMEROUS FACTORS AND FUTURE EVENTS COULD CAUSE THE COMPANY TO CHANGE SUCH PLANS AND OBJECTIVES OR FAIL TO SUCCESSFULLY IMPLEMENT SUCH PLANS OR ACHIEVE SUCH OBJECTIVES, OR CAUSE SUCH PRESENT AND FUTURE OPERATIONS TO FAIL TO PRODUCE REVENUES, INCOME OR PROFITS. THEREFORE, THE READER IS ADVISED THAT THE FOLLOWING DISCUSSION SHOULD BE CONSIDERED IN LIGHT OF THE DISCUSSION OF RISKS AND OTHER FACTORS CONTAINED IN THIS REPORT ON FORM 10-K AND IN THE COMPANY'S REGISTRATION STATEMENT ON FORM S-1 FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 6, 2014. NO STATEMENTS CONTAINED IN THE FOLLOWING DISCUSSION SHOULD BE CONSTRUED AS A GUARANTEE OR ASSURANCE OF FUTURE PERFORMANCE OR FUTURE RESULTS.

Overview

NanoFlex is engaged in the development, commercialization, and licensing of advanced photovoltaic technologies and intellectual property. We have agreements with Princeton University which were assigned to University of Southern California and the University of Michigan (collectively, the “Universities”), pursuant to which we have developed certain technologies and prosecuted and paid for more than 750 issued or pending patents  covering materials, architectures, and fabrication processes for organic and inorganic flexible, thin-film photovoltaic technologies. While each patent is issued in the names of the respective university that developed the subject technology, we have exclusive commercial license rights to all of the patents and their attendant technologies and the patents are referred to herein as being our patents.

Unlike conventional thin film solar, the materials platforms that we have developed and are developing for solar cells are capable of ultrahigh efficiency accessible only by single crystalline inorganic materials such as silicon and gallium arsenide.  The technologies we are developing allow the solar energy generating surfaces to be sufficiently flexible to be wrapped around 1 centimeter diameter cylinders without damage or loss of performance.  Their ultra-light weight impacts other traditional costs associated with solar such as eliminating the need for costly, complex and robust panel mounts. We believe that these solar energy generating “films” can be used on architectural surfaces, on windows as attractive semi-transparent energy-generating coatings and even paints. Their flexibility allows their application to surfaces such as tents, clothing and other oddly shaped or “mobile” surfaces, including space-borne applications.  Finally, the ability to be rolled around cylinders permits compact and low cost transport for deployment at remote sites.

We currently hold exclusive rights to more than 750 issued or pending patents worldwide which cover architecture, processes and materials for flexible, thin-film organic photovoltaic (“OPV”) and Gallium Arsenide (“GaAs”) technologies.  In addition, we have several hundred more patents in process. Some of our technology holdings include foundational concepts in the following areas (many of which are being validated in other labs as indicated by the asterisks).

● Tandem organic solar cell*

● Fullerene acceptors*

● Blocking layers*

● New materials for visible and infrared sensitivity*

● Scalable growth technologies*

● Inverted solar cells*

● Materials for enhanced light collection via multiexciton generation

● Mixed layer and nanocrystalline cells

● Solar paints

● Transparent/semi-transparent cells

● Ultralow cost, ultrahigh efficiency, flexible thin film inorganic cells

● Accelerated and recyclable liftoff process

● Cold-weld bonding of inorganic solar cells to plastic substrates and metal foils

Plan of Operation and Liquidity and Capital Resources

We are solely dependent on raising capital to support its operations at this time. As of the date of filing this report, we lack sufficient capital to pay for ongoing research and development operations. Should we be unable to raise the additional capital that we need, we may not be able to continue those operations and will need to further change our plans to scale back activities based on whether and when capital is available. We are in the process of raising additional funds.  The additional funding, if it can be raised, is anticipated to consist of private sales of our equity securities and/or convertible debt instruments.   However, there can be no assurance that the additional funds will be available to us when needed.

We are actively taking measures to decrease costs as well as manage payables in order to conserve capital resources. As part of these measures, NanoFlex negotiated a permanent decrease in salaries with its employees, has modified its operating plan as set forth below and is managing payables to prioritize the most important of them to keep research and development activities going.

9

Near Term Operating Plan

Our current burn rate is approximately $5,000,000 per year in order to support our research and development activities, maintain our existing patent portfolio and make necessary payments under our Sponsored Research Agreement. Our operating plan over the next twelve months is comprised of the following:

1. Cost cutting and containment to reduce our annual burn rate;

2. Maintenance of our existing patent portfolio;

3. Continuing ongoing research and development activities;

4. Partnering with strategic partners for licensing and/or joint development of our technologies; and

5. Raising not less than $5,000,000 in capital.

In the event that we raise less than the required amount of capital, our focus will be maintenance of our existing patent portfolio and less spending on ongoing research and development.

In the event an additional $5.5 million in capital can be raised, we will invest in build out and equipment purchases for a technology development center as described below.

There can be no assurance that our near term operating plan will be successful or that we will be able to fulfill it as it is largely dependent on raising capital and there can be no assurance that capital can be raised.

Overall Operating Plan

We have made contact with major solar cell and electronics manufacturers world-wide and are finding commercial interest in both our GaAs and OPV technologies. We are seeking to work closely with those companies interested in our technology solutions to develop proof-of-concept prototypes and processes to mitigate commercialization risks and gain early market entry and acceptance.

Although we currently do not have any commitments from third parties to license our technologies or otherwise provide revenue to us, we are aware of several laboratories and commercial suppliers who are exploring and positively validating technologies that we have developed and which are protected by our intellectual property portfolio.  These interested parties potentially represent some of our first partners for joint technology development and acceptance into manufacturing production.

A key to reducing the risk to market entry by our partners is for us to qualify our technologies at a manufacturing scale.  We believe that the best manner to do this is to develop our own technology development center in Ann Arbor, Michigan.   The principal function of the facility will be to demonstrate our ability to prototype our inorganic and organic solar cells utilizing our proprietary technologies.  In addition, we anticipate that advancements at the facility can attract other industry players to acquire early licenses to use our intellectual property.  Finally, we believe that having a technology development center will allow us to obtain government funding from the National Aeronautics and Space Administration, the Department of Defense and the Department of Energy, each of which have interests in businesses that can deliver ultra-lightweight, high-efficiency technologies for space, mobile warfighter, and grid-deployment applications.

We believe the technology development center can also make us highly competitive to receive government grants to support GaAs and OPV research and development. A second potential revenue source is in joint development projects with existing solar cell manufacturers. We believe the largest near-term opportunity can be in partnerships exploiting GaAs solar technology with existing GaAs cell manufacturers in the space programs, military operations and other suitable end use. We anticipate that partnerships with one or more of these companies can be supported by the facility, and possibly result in early revenue opportunities. 

We believe that the costs of establishing the facility will be approximately $4,300,000.

Our long term overall plan of operation is dependent upon our ability to raise additional capital to support our research and development operations.  Since our inception, we have raised over $53,000,000 in equity from various investors, which has been invested primarily in research and development activities and maintaining our patent portfolio.  We anticipate that we will need to raise approximately $17,700,000 over the next 24 months until we earn sufficient revenue to support our operations, including our continuing research and development activities and patent prosecutions and to maintain our intellectual property portfolio.  The following is a breakdown of the $17,700,000 budget:

Working Capital	$	2,700,000
R&D Sponsored Research	$	3,600,000
R&D Operating Expenses (technology development center)	$	1,300,000
R&D Equipment Purchases (technology development center)	$	2,950,000
Patent Prosecution and App Fees	$	3,600,000
General and Administrative	$	3,550,000

There can be no assurance that financing will be available to us to fund our $17,700,000 budget, or, if available, that it will be on terms acceptable to us.

Recent Development

On October 22, 2014, the University of Michigan, our research partner, won a $1.35 million cooperative award under the U.S. Department of Energy SunShot Initiative. The University of Michigan was selected as part of SunShot’s “Next Generation Photovoltaics 3” program and was the only project awarded for OPV research and development.

This project aims to advance the practical viability of OPV by demonstrating reliable, large area and high-efficiency organic multijunction cells based on small molecule materials systems. The implementations in academic labs will be transferred to NanoFlex Power Corp., as the University of Michigan’s commercialization partner, who will work with manufacturers to achieve acceptance and deployment of OPV technology. The goals of the University of Michigan’s proposed program are: 1) demonstration of multijunction organic solar cells with efficiencies of >18%, 2) demonstration of extrapolated multijunction cell lifetimes exceeding 20 years, 3) demonstration of ultra-rapid organic film deposition on continuous rolls of foil substrates using our proprietary technology of organic vapor phase deposition; and 4) demonstration of roll-to-roll (R2R) application of package encapsulation.

10

Results of Operations

For the Three and Nine Months Ended September 30, 2014 and September 30, 2013

Research and Development Expenses

Research and development expenses for the three months ended September 30, 2014 were $291,571, a 29% decrease from $412,440 for the three months ended September 30, 2013.  The decrease is attributable to timing of research work by the Universities performed pursuant to our research agreements. Research and development expenses for the nine months ended September 30, 2014 were $996,722, a 4% increase from $956,211 for the nine months ended September 30, 2013. The increase is attributable to additional funding we provided to the Universities pursuant to our research agreements.

Patent Application and Prosecution Fees

Patent application and prosecution fees consist of the fees due for prosecuting and maintaining our patents and were $625,595 for the three months ended September 30, 2014, a 9% decrease from $690,996 for the three months ended September 30, 2013. The decrease is attributable to timing of applications being researched for our technologies. Patent application and prosecution fees were $1,367,998 for the nine months ended September 30, 2014, an 8% increase from $1,263,417 for the nine months ended September 30, 2013. The increase is attributable to an increase in the number of our patents and number of applications being researched for our technologies.

Salaries and Related Expenses

Salaries and related expenses were $399,164 for the three months ended September 30, 2014, a 52% decrease from $835,985 for the three months ended September 30, 2013. Salaries and related expenses were $1,241,256 for the nine months ended September 30, 2014, a 10% decrease from $1,373,281 for the nine months ended September 30, 2013. The decrease is attributable to a negotiated temporary decline in salaries during the first quarter of 2013 which was subsequently reinstated. In October 2014, a permanent decrease in salaries was negotiated with the Company’s employees in an effort to conserve capital resources.

Stock-based Compensation

There was no stock-based compensation for the three and nine months ended September 30, 2014 as compared to $6,657,689 and $26,064,190 for the three and nine months ended September 30, 2013, respectively, relating to the vesting of awards granted in 2012.  As of September 30, 2014, there was no remaining unamortized stock-based compensation associated with outstanding awards.

Selling, General and Administrative Expenses

Selling, general and administrative expenses, consisting primarily of rent, office supplies, depreciation, workers compensation insurance, medical insurance, postage and shipping, traveling expenses and consulting fees, were $288,904 for the three months ended September 30, 2014, a 65% decrease from $832,414 for the three months ended September 30, 2013.  Selling, general and administrative expenses were $774,499 for the nine months ended September 30, 2014, a 32% decrease from $1,143,121 for the nine months ended September 30, 2013. The decrease is primarily attributable to decreases in legal and consulting fees.

Interest Expense

Interest expense for the three and nine months ended September 30, 2014 was $42,631 as compared to $17,932 and $4,463,453 for the three and nine months ended September 30, 2013, respectively, due to the effects of our reverse merger which eliminated all of our interest bearing debt. We entered into new interest bearing debt agreements in 2014 which are discussed in Note 2 and Note 3.

Loss on Debt Extinguishment

There was no loss on debt extinguishment for the three and nine months ended September 30, 2014 as compared to $0 and $1,811,800 for the three and months ended September 30, 2013, respectively, as we have eliminated all of our interest bearing debt.  The loss on debt extinguishment in 2013 related to (i) conversion of $230,000 of debt that was not originally convertible into 46,000 common shares and (ii) the issuance of 286,000 of common shares in connection with the extension of the maturity date on an aggregate of $1,400,000 of outstanding debt.  We evaluated the modifications under ASC 470-50 and determined that the modifications were substantial and the revised terms constituted debt extinguishments for which a loss is recognized equal to the difference in fair value of the debt and shares before and after the modifications.

Net Loss

The net loss for the three months ended September 30, 2014 was $1,647,866 an 83% decrease from $9,447,456 for the three months ended September 30, 2013.  The net loss for the nine months ended September 30, 2014 was $4,423,106, a 88% decrease from $37,075,473 for the nine months ended September 30, 2013. The decrease in the net loss is impacted by the decrease in stock-based compensation, interest expense and loss on debt extinguishment, each of which is described above.

11

Liquidity and Capital Resources

As of September 30, 2014, we had cash and cash equivalents of $51,011 and a working capital deficit of $3,832,228, as compared to cash and cash equivalents of $197,004 and a working capital deficit of $1,255,222 as of December 31, 2013.  The decrease in cash and working capital is attributable to our operating losses as we have yet to generate revenues from our operations. 

We are in the process of raising additional funds in order to continue to finance our near term and overall plans for research, development and commercialize photonic energy conversion technologies utilizing organic semiconductor-based solar cells.  The additional funding, if it can be raised, is anticipated to consist of private sales of our equity securities and/or convertible debt instruments.   However, there can be no assurance that the additional funds will be available to us when needed.

The Company is actively taking measures to decrease costs as well as manage payables in order to conserve capital resources. As part of these measures, the Company negotiated a permanent decrease in salaries with its employees.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Critical Accounting Policies

There were no changes in our critical accounting policies during the three months ended September 30, 2014 from those set forth in “Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC on March 31, 2014.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 as a process designed by, or under the supervision of, the Company’s principal executive and principal financial officers and effected by the Company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and

● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

As of September 30, 2014, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on that evaluation, they concluded that, during the period covered by this report, such internal controls and procedures were not effective to detect the inappropriate application of US GAAP rules as more fully described below. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were:

(1) We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness;

(2) The Company’s board of directors has no audit committee, independent director or member with financial expertise which causes ineffective oversight of the Company’s external financial reporting and internal control over financial reporting;

12

(3) We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness;

(4) We lack the financial infrastructure to account for complex transactions which may result in a greater than normal risk that material errors may occur in the financial statements and not be detected timely; and

(5) We lack qualified resources to perform the internal audit functions properly, and the scope and effectiveness of the internal audit function are yet to be developed. Specifically, the reporting mechanism between the accounting department and the Board of Directors and the CFO was not effective.

The aforementioned material weaknesses were identified by our Chief Executive Officer and Chief Financial Officer in connection with the review of our financial statements as of September 30, 2014.

Management’s Remediation Initiatives

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we have initiated, or plan to initiate, the following series of measures:

We intend to create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us. And, we plan to appoint one or more outside directors to our board of directors who shall be appointed to an audit committee resulting in a fully functioning audit committee who will undertake the oversight in the establishment and monitoring of required internal controls and procedures such as reviewing and approving estimates and assumptions made by management when funds are available to us.  We will also be working with our independent registered public accounting firm and refining our internal procedures.

Changes in Internal Control over Financial Reporting

Our management has also evaluated our internal control over financial reporting, and there have been no significant changes in our internal controls or in other factors that could significantly affect those controls subsequent to the date of our last evaluation.

Subsequent to the period covered by the report, management is implementing measures to remediate the material weaknesses in internal controls over financial reporting described above. Specifically, the CEO, President and the CFO are seeking to improve communications regarding the importance of documentation of their assessments and conclusions of their meetings, as well as supporting analyses.  As the business increases, the Company is seeking to hire accounting professionals and it will continue its efforts to create an effective system of disclosure controls and procedures for financial reporting.

The Company is not required by current SEC rules to include, and does not include, an auditor's attestation report. The Company's registered public accounting firm has not attested to Management's reports on the Company's internal control over financial reporting.

13

PART II - OTHER INFORMATION

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

From January through September of 2014, the Company sold and issued to certain investors an aggregate of 1,483,000 shares of Common Stock and warrants to purchase an aggregate of 1,483,000 shares of Common Stock for gross proceeds of $1,853,750.

In July 2014, the Company borrowed $500,000 under two short term note agreements of $250,000 each.  Under the terms of each agreement, the principal balance of $250,000 and interest of $16,500 is due to be repaid within 4 months of the date of the note.

The above issuance of the Company’s securities was not registered under the Securities Act of 1933, as amended (the “1933 Act”), and the Company relied on an exemption from registration provided by Rule 506(b) of Regulation D promulgated under the 1933 Act for such issuance.

Except as disclosed above, all unregistered sales of the Company’s securities have been disclosed on the Company’s current reports on Form 8-K and the Company’s quarterly reports on Form 10-Q.

ITEM 6.  EXHIBITS.

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Operating Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.3	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Principal Executive Officers and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.**
101.SCH	XBRL Taxonomy Extension Schema Document.**
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.**
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.**
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.**
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.**

** Users of this data are advised pursuant to Rule 406T of Regulation S-X that this interactive data file is deemed not filed or part of a registration statement or prospectus for the purpose of section 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

14

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NANOFLEX POWER CORPORATION
Date: November 14, 2014	By:	/s/ Dean L. Ledger
		Dean L. Ledger
		Chief Executive Officer (principal executive officer)
Date: November 14, 2014	By:	/s/ Robert J. Fasnacht
		Robert J. Fasnacht
		President and Chief Operating Officer (principal executive officer)
Date: November 14, 2014	By:	/s/ Amy B. Kornafel
		Amy B. Kornafel
		Chief Financial Officer
		(principal financial officer and principal accounting officer)

15 

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Dean L. Ledger, Chief Executive Officer of NanoFlex Power Corporation, formerly known as Universal Technology Systems Corp. (the “registrant”), certify that:

1.	I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended September 30, 2014;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  November 14, 2014

/s/ Dean L. Ledger

     Dean L. Ledger

     Chief Executive Officer

     (principal executive officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Robert J. Fasnacht, President and Chief Operating Officer of NanoFlex Power Corporation, formerly known as Universal Technology Systems Corp. (the “registrant”), certify that:

1.	I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended September 30, 2014;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  November 14, 2014

/s/ Robert J. Fasnacht

     Robert J. Fasnacht

     President and Chief Operating Officer

     (principal executive officer)

EX-31.3

Exhibit 31.3

CERTIFICATION

I, Amy B. Kornafel, Chief Financial Officer of NanoFlex Power Corporation, formerly known as Universal Technology Systems Corp. (the “registrant”), certify that:

1.	I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended September 30, 2014;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  November 14, 2014

/s/ Amy B. Kornafel

     Amy B. Kornafel

     Chief Financial Officer

     (principal financial officer and accounting officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, in his or her capacity as an officer of NanoFlex Power Corporation, formerly Universal Technology Systems Corp. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his/her knowledge:

(1)    The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2014  (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  November 14, 2014

/s/ Dean L. Ledger

     Dean L. Ledger

     Chief Executive Officer

     (principal executive officer)

/s/ Robert J. Fasnacht

     Robert J. Fasnacht

     President and Chief Operating Officer

     (principal executive officer)

/s/ Amy B. Kornafel

     Amy B. Kornafel

     Chief Financial Officer

     (principal financial officer and accounting officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Equity

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

EQUITY

4. EQUITY

During the nine months ended September 30, 2014, the Company sold an aggregate of 1,483,000 units at $1.25 per unit for aggregate proceeds of $1,853,750. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.

XML

Notes Payable - Related Party

9 Months Ended

Sep. 30, 2014

Notes Payable - Related Party [Abstract]

NOTES PAYABLE - RELATED PARTY

3. NOTES PAYABLE - RELATED PARTY

On February 26, 2014, the Company borrowed $150,000 under a short term note agreement with a related party. Under the terms of this agreement, this note is due to be repaid within 6 months of funding and is non-interest bearing.  If the Company defaults on this agreement, the note shall bear interest at a rate of 18 percent per annum for the entire term of the note. In November 2014, the note agreement was amended to extend the due date to February 26, 2015, 12 months from the date of the note. As of September 30, 2014, $90,000 is due under this agreement.

During the three months ended September 30, 2014, the Company received advances totaling $76,000 and repaid advances totaling $155,000. During the nine months ended September 30, 2014, the Company received advances totaling $443,000 and repaid advances totaling $233,000.

XML

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash	$ 51,011	$ 197,004
Prepaid expenses and other current assets	8,624	13,645
Total current assets	59,635	210,649
Property and equipment, net	15,083	7,433
TOTAL ASSETS	74,718	218,082
CURRENT LIABILITIES:
Accounts payable	1,671,986	689,119
Accrued expenses	1,319,877	676,752
Short-term debt	600,000	100,000
Short-term debt- related party	90,000
Advances - related party	210,000
Total current liabilities	3,891,863	1,465,871
TOTAL LIABILITIES	3,891,863	1,465,871
STOCKHOLDERS' DEFICIT:
Common stock, 250,000,000 authorized, $0.0001 par value, 44,282,278 and 42,799,278 issued and outstanding, respectively	4,428	4,280
Additional paid in capital	172,864,561	171,010,959
Accumulated deficit	(176,686,134)	(172,263,028)
Total stockholders' deficit	(3,817,145)	(1,247,789)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 74,718	$ 218,082

XML

Background Basis of Presentation, and Going Concern

9 Months Ended

Sep. 30, 2014

Background, Basis of Presentation, and Going Concern [Abstract]

BACKGROUND, BASIS OF PRESENTATION, AND GOING CONCERN

1. BACKGROUND, BASIS OF PRESENTATION, AND GOING CONCERN:

Background

Global Photonic Energy Corporation merged with NanoFlex Power Corporation (formerly, Universal Technology Systems Corp., the “Company”) in a share exchange transaction recorded as a reverse merger on September 24, 2013.  The Company is organized to fund, develop and commercialize photonic energy conversion technologies utilizing organic semiconductor-based solar cells.  The Company intends to enter into licensing arrangements and other strategic alliances for the development, manufacture and marketing of products utilizing this technology. The Company is devoting substantially all of its present efforts to establishing a new business.

Basis or Presentation

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the fiscal year ended December 31, 2013 included in our Annual Report on Form 10-K. The results of operations for the three and nine months ended September 30, 2014 are not necessarily indicative of results to be expected for the full fiscal year or any other periods.

The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make a number of estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosures. Actual results may differ from these estimates.

In the quarter ending September 30, 2014, the Company has elected to early adopt Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. The adoption of this ASU allows the Company to remove the inception to date information and all references to development stage.

Going Concern

The Company has not generated revenues to date.  The Company has a working capital deficit of ($3,832,228) and an accumulated deficit of ($176,686,134) as of September 30, 2014.  The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations.  Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. To date, the Company has funded its initial operations primarily by way of the sale of equity securities, convertible note financing, short term financing from private parties, and advances from related parties.

XML

Notes Payable

9 Months Ended

Sep. 30, 2014

Notes Payable [Abstract]

NOTES PAYABLE

2. NOTES PAYABLE

In July 2014, the Company borrowed $500,000 under two short term note agreements of $250,000 each. Under the terms of each agreement, the principal balance of $250,000 and interest of $16,500 is due to be repaid within 4 months of the date of the note. At September 30, 2014, $33,000 was recorded as accrued interest relating to these notes.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Balance Sheets [Abstract]
Common Stock, shares authorized	250,000,000	250,000,000
Common Stock, par value per share	$ 0.0001	$ 0.0001
Common Stock, shares issued	44,282,278	42,799,278
Common Stock, shares, outstanding	44,282,278	42,799,278

XML

Stock Options and Warrants (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares, Outstanding	105,000
Number of shares, Granted
Number of Shares, Cancelled	(47,000)
Number of Shares, Exercised
Number of Shares, Outstanding	58,000
Number of Shares, Exercisable	58,000
Weighted Average Exercise Price, Outstanding	$ 11.03
Weighted Average Exercise Price, Cancelled	$ 10.31
Weighted Average Exercise Price, Outstanding	$ 11.62
Weighted Average Exercise Price, Exercisable	$ 11.62
Weighted Average Remaining Contractual Term Outstanding	2 years 7 months 6 days
Weighted Average Remaining Contractual Term Outstanding	3 years 2 months 12 days
Weighted Average Remaining Contractual Term Outstanding Exercisable	3 years 2 months 12 days
Aggregate Intrinsic Value Outstanding
Aggregate Intrinsic Value Outstanding
Aggregate Intrinsic Vallue Exercisable
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares, Outstanding	19,556,983
Number of shares, Granted	1,483,000
Number of Shares, Cancelled
Number of Shares, Exercised
Number of Shares, Outstanding	21,039,983
Number of Shares, Exercisable	21,039,983
Weighted Average Exercise Price, Outstanding	$ 3.60
Weighted Average Exercise Price, Granted	$ 2.50
Weighted Average Exercise Price, Outstanding	$ 3.02
Weighted Average Exercise Price, Exercisable	$ 3.02
Weighted Average Remaining Contractual Term Outstanding	4 years 8 months 12 days
Weighted Average Remaining Contractual Term Outstanding	4 years 6 months
Weighted Average Remaining Contractual Term Outstanding Exercisable	4 years 6 months
Aggregate Intrinsic Value Outstanding
Aggregate Intrinsic Value Outstanding
Aggregate Intrinsic Vallue Exercisable

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 07, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	NanoFlex Power Corp
Entity Central Index Key	0001571636
Amendment Flag	false
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		44,282,278

XML

Stock Options and Warrants (Details Textual) (USD $)	9 Months Ended
	Sep. 30, 2014
Stock Options And Warrants (Textual)
Warrants granted during the period	860,150
Number of options to purchase common stock	2,000,000
Stock Options [Member] | Minimum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 10.00
Stock Options [Member] | Maximum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 15.00
Warrant [Member] | Minimum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 2.50
Warrant [Member] | Maximum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 17.50
Warrant [Member] | Exercise Price Range One [Member] | Minimum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 12.00
Warrant [Member] | Exercise Price Range One [Member] | Maximum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 17.50
Warrant [Member] | Exercise Price Range Two [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	$ 2.50

XML

Condensed Consolidated Statements Of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
OPERATING EXPENSES:
Research and development	$ 291,571	$ 412,440	$ 996,722	$ 956,211
Patent application and prosecution fees	625,596	690,996	1,367,998	1,263,417
Salaries and related expenses	399,164	835,985	1,241,256	1,373,281
Stock-based compensation		6,657,689		26,064,190
Selling, general and administrative expenses	288,904	832,414	774,499	1,143,121
Total operating expenses	1,605,235	9,429,524	4,380,475	30,800,220
LOSS FROM OPERATIONS	1,605,235	9,429,524	4,380,475	30,800,220
OTHER INCOME (EXPENSES):
Interest expense	(42,631)	(17,932)	(42,631)	(4,463,453)
Loss on extinguishment of debt				(1,811,800)
Total other expense	(42,631)	(17,932)	(42,631)	(6,275,253)
LOSS BEFORE INCOME TAX BENEFIT	1,647,866	9,447,456	4,423,106	37,075,473
INCOME TAX BENEFIT
NET LOSS	$ (1,647,866)	$ (9,447,456)	$ (4,423,106)	$ (37,075,473)
NET LOSS per share (basic and diluted)	$ (0.04)	$ (0.42)	$ (0.10)	$ (0.61)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC and DILUTED	43,923,961	22,589,971	43,420,085	61,079,624

XML

Stock Options and Warrants (Tables)

9 Months Ended

Sep. 30, 2014

Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Stock Option and Warrants Activity

						Weighted Average
				Weighted		Remaining
				Average		Contractual		Aggregate
	Number of			Exercise		Term		Intrinsic
	Shares			Price		(in years)		Value
Outstanding as of December 31, 2013		105,000		$	11.03		2.6	$	-
Granted		-
Cancelled		(47,000	)	$	10.31
Exercised		-
Outstanding as of September 30, 2014		58,000		$	11.62		3.2	$	-
Exercisable as of September 30, 2014		58,000		$	11.62		3.2	$	-

Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Stock Option and Warrants Activity

					Weighted Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Term		Intrinsic
	Shares		Price		(in years)		Value
Outstanding as of December 31, 2013		19,556,983	$	3.60		4.7	$	-
Granted		1,483,000	$	2.50
Cancelled		-
Exercised		-
Outstanding as of September 30, 2014		21,039,983	$	3.02		4.5	$	-
Exercisable as of September 30, 2014		21,039,983	$	3.02		4.5	$	-

XML

Subsequent Events

9 Months Ended

Sep. 30, 2014

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

6. SUBSEQUENT EVENTS

In October 2014, a permanent decrease in salaries was negotiated with the Company’s employees in an effort to conserve capital resources.

XML

Notes Payable - Related Party (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Feb. 26, 2014	Dec. 31, 2013
Notes Payable Textual [Abstract]
Short-term debt- related party	$ 90,000	$ 90,000		$ 150,000
Debt instrument interest rate				18.00%
Advances received from related party	76,000	(443,000)
Advances repaid to related party	155,000	233,000
Maturity Date		Feb. 26, 2015
Related Party [Member]
Notes Payable Textual [Abstract]
Related party transactions amounts due	$ 90,000	$ 90,000

XML

Background Basis of Presentation, and Going Concern (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Background Basis of Presentation (Textual)
Working capital deficit	$ (3,832,228)
Accumulated deficit	$ (176,686,134)	$ (172,263,028)

XML

Notes Payable (Details) (USD $)	1 Months Ended	9 Months Ended
	Jul. 31, 2014 Note	Sep. 30, 2014
Notes Payable (Textual)
Proceeds from short term note borrowed	$ 500,000
Short term note agreements	250,000
Principal balance outstanding for short term not during the period	250,000
Interest due on short term note	16,500
Number of short term notes borrowed	2
Accrued interest		$ 33,000

XML

Equity (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Equity Textual [Abstract]
Sale of stock, per share price	$ 1.25
Sale of stock and warrant, description	Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.
Warrants exercisable price per share	$ 2.50
Sale of common shares, shares	1,483,000
Sale of common shares, Value	$ 1,853,750
Warrant exercisable period	5 years

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,423,106)	$ (37,075,473)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,414	2,879
Amortization of debt discounts		45,421
Stock-based compensation		26,064,190
Interest expense from convertible debt converted to preferred shares		57,915
Interest expense from additional common shares issued		4,015,040
Loss on extinguishment of debt		1,811,800
Return of equity investment		(222,500)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	5,021	12,784
Accounts payable and accrued expenses	1,625,992	(1,946,512)
Net cash used in operating activities	(2,789,679)	(7,234,456)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of fixed assets	(10,064)
Common shares issued in reverse merger, net		5,049
Net cash used in investing activities	(10,064)	5,049
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of warrants		176,819
Proceeds from sale of common shares and warrants	1,853,750	1,050,000
Advances received from related party	443,000
Advances repaid to related party	(233,000)
Borrowings on related party debt	150,000	240,000
Borrowings on convertible debt - related party		6,800,000
Borrowings on debt	500,000
Borrowing on convertible debt		2,124,500
Principal repayments on debt		(1,725,000)
Principal repayments on related party debt	(60,000)	(640,000)
Net cash provided by financing activities	2,653,750	8,026,319
NET DECREASE IN CASH	(145,993)	796,912
Cash, beginning of the period	197,004	344,656
Cash, end of the period	51,011	1,141,568
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest		714,036
Cash paid for income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Warrants and common shares issued for debt		230,000
Common share issued for forgiveness of related party debt		105,000
Common shares issued for conversion of convertible debt upon merger		$ 11,433,200

XML

Stock Options and Warrants

9 Months Ended

Sep. 30, 2014

Stock Options and Warrants & Stock Based Compensation [Abstract]

STOCK OPTIONS AND WARRANTS

5. STOCK OPTIONS AND WARRANTS

2000 Stock Option Plan

On April 28, 2000, the Board of Directors adopted the 2000 Stock Option Plan.  Under the Plan, the Company may grant incentive stock options to employees and non-qualified stock options to employees, non-employee directors and/or consultants. The Plan provides for the granting of a maximum of 2,000,000 options to purchase common stock.  The ISO exercise price per share may not be less than the fair market value of a share on the date the option is granted.  The maximum term of the options may not exceed ten years.

A summary of stock option activity during the nine months ended September 30, 2014 is as follows:

						Weighted Average
				Weighted		Remaining
				Average		Contractual		Aggregate
	Number of			Exercise		Term		Intrinsic
	Shares			Price		(in years)		Value
Outstanding as of December 31, 2013		105,000		$	11.03		2.6	$	-
Granted		-
Cancelled		(47,000	)	$	10.31
Exercised		-
Outstanding as of September 30, 2014		58,000		$	11.62		3.2	$	-
Exercisable as of September 30, 2014		58,000		$	11.62		3.2	$	-

The exercise price of these options range from $10.00 to $15.00 per share.

A summary of warrant activity during the nine months ended September 30, 2014 is as follows:

					Weighted Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Term		Intrinsic
	Shares		Price		(in years)		Value
Outstanding as of December 31, 2013		19,556,983	$	3.60		4.7	$	-
Granted		1,483,000	$	2.50
Cancelled		-
Exercised		-
Outstanding as of September 30, 2014		21,039,983	$	3.02		4.5	$	-
Exercisable as of September 30, 2014		21,039,983	$	3.02		4.5	$	-

The exercise price of these warrants ranges from $2.50 to $17.50 per share.

During the three months ended March 31, 2014, the Company modified an aggregate of 860,150 of warrants to reduce their exercise price from a range of $12.00 to $17.50 per share to $2.50 per share.  All other terms and conditions remained the same.  The Company determined that this transaction did not constitute a modification under ASC 718-10 or ASC 505-50 as it met the scope exceptions for a transaction with an investor or lender.  Accordingly, no expense was recognized in connection with these transactions.